Compare AMETEK, Inc. (AME) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AMETEK, Inc. vs Moderna, Inc. — how do they compare? AMETEK, Inc. trades at $232.13 (market cap $53.63B), while Moderna, Inc. trades at $66.81 (market cap $27.09B). The key difference: AMETEK, Inc. is the larger of the two by market cap, and AMETEK, Inc. pays a 0.58% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| AME | MRNA | |
|---|---|---|
Market Cap | $53.63B | $27.09B |
Sector | Industrials | Health |
52-Week High | $241.94 | $81.80 |
52-Week Low | $176.44 | $22.36 |
Enterprise Value | $55.33B | $23.18B |
Dividend Yield | 0.58% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AMETEK, Inc.
Ametek is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. About half of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.
Read more on AME →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
